CAMC Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, CAMC Health System sits in the top decile of US sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count).
CAMC Health System: 28 sponsored US clinical trials, 3 recruiting.
CAMC Health System sponsors 28 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 17 completed. 5 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Interventional Radiology, with 2 trials.
Top-decile sponsor footprint
CAMC Health System ranks in the top decile of sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
17 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (70.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
28 total, page 1 of 1
Prospective IR-led Sedation Feasibility
NCT07443254
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
NCT06764966
Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System
NCT04279457
Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology
NCT07040163
Pregabalin vs. Gabapentin on Reducing Opioid Usage
NCT04705480
Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures
NCT04003012
Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study
NCT03699982
Intravenous Lidocaine for Cystectomy Procedures
NCT02924480
Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study
NCT02417168
Effect of Infant Immunization on Procalcitonin Levels - A Pilot Study
NCT04295694
A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study
NCT01916616
Ultrasound Versus Fluoroscopically-guided Arterial Access in Non-cardiac Vascular Patients
NCT01612026
The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient
NCT01424345
Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients
NCT01426165
Can Neck Circumference Measurements Less Than 43cm or Greater Than 43cm Predict Difficulty of Tracheal Intubation?
NCT01191658
Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy
NCT01184183
Phospholipase A2 Producing Bacteria and Pre-Term Labor
NCT00855543
Ureteral Stent Size Measurement Study
NCT00919386
Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis
NCT00873171
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
NCT00873054
Study of the Effect of Neck Treatment on Shoulder Impingement
NCT00764764
Correlation of Cerebral State Index With the Richmond Agitation-Sedation Scale in Mechanically Ventilated ICU Patients
NCT00855075
Weekly Phone Calls Versus Brief Patient Education to Improve Continuous Positive Airway Pressure (CPAP) Compliance
NCT00945776
Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis
NCT00967941
Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients
NCT00799201
Selective Versus Routine Shunting in Carotid Endarterectomy Patients
NCT00967486
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
NCT00940966
Education Program for Family Caregivers
NCT00764647
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
| Phase 4 | 5 |
What is open in the CAMC Health System pipeline
3 recruiting of 28 indexed (11% open); 17 completed (61%).
Phase mix: 5 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Interventional Radiology (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
CAMC Health System: open-pipeline peers nationwide
Peers matched on 28 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
CAMC Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 28 trials (± recruiting share)
- Axsome Therapeutics · 28 trials · 21% recruiting
- Benaroya Research Institute · 28 trials · 14% recruiting
- CTI BioPharma · 28 trials · 0% recruiting
- Harvard Pilgrim Health Care · 28 trials · 4% recruiting
Sponsors near 11% open enrollment (± trial volume)
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
- Tufts Medical Center · 11% recruiting · 169 trials
- Carnegie Mellon University · 11% recruiting · 37 trials
Related
What to do with this CAMC Health System page
28 registered trials is a research-attention snapshot, not an endorsement of CAMC Health System or any single study.
- 3 of CAMC Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Interventional Radiology is the condition CAMC Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Interventional Radiology trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
CAMC Health System pipeline card: 28 registered trials from official public datasets.Report a data error.